Wellcome unveiled strong sales forecasts for its main medicines in 2019 in what was seen as a defensive move on Wednesday showing that a hostile bid of 2.7 billion pounds Lrb 10 billion dollars Rrb by Glaxo undervalued the company.
Wellcome presents glowing sales forecast to fend off Glaxo.